A detailed history of Exodus Point Capital Management, LP transactions in Staar Surgical CO stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 240,740 shares of STAA stock, worth $6.57 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
240,740
Holding current value
$6.57 Million
% of portfolio
0.05%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$29.97 - $47.42 $7.21 Million - $11.4 Million
240,740 New
240,740 $8.94 Million
Q4 2022

Feb 13, 2023

BUY
$46.82 - $76.2 $1.98 Million - $3.23 Million
42,325 Added 363.37%
53,973 $2.62 Million
Q3 2022

Nov 10, 2022

SELL
$70.55 - $111.58 $733,367 - $1.16 Million
-10,395 Reduced 47.16%
11,648 $822,000
Q2 2022

Aug 19, 2022

BUY
$50.24 - $80.48 $1.11 Million - $1.77 Million
22,043 New
22,043 $1.56 Million
Q1 2022

May 13, 2022

SELL
$57.98 - $93.5 $1.88 Million - $3.03 Million
-32,416 Closed
0 $0
Q4 2021

Feb 11, 2022

BUY
$88.02 - $127.79 $2.1 Million - $3.04 Million
23,824 Added 277.28%
32,416 $2.96 Million
Q3 2021

Nov 15, 2021

BUY
$122.75 - $162.68 $1.05 Million - $1.4 Million
8,592 New
8,592 $1.1 Million
Q3 2020

Nov 16, 2020

SELL
$45.65 - $61.81 $576,422 - $780,474
-12,627 Closed
0 $0
Q2 2020

Aug 14, 2020

SELL
$29.15 - $61.54 $450,746 - $951,593
-15,463 Reduced 55.05%
12,627 $777,000
Q1 2020

May 15, 2020

SELL
$25.01 - $42.4 $1.19 Million - $2.02 Million
-47,622 Reduced 62.9%
28,090 $906,000
Q4 2019

Feb 14, 2020

BUY
$24.55 - $38.13 $1.63 Million - $2.53 Million
66,320 Added 706.13%
75,712 $2.66 Million
Q3 2019

Nov 14, 2019

SELL
$25.78 - $34.8 $1,907 - $2,575
-74 Reduced 0.78%
9,392 $242,000
Q2 2019

Aug 14, 2019

BUY
$23.08 - $37.01 $218,475 - $350,336
9,466 New
9,466 $278,000

Others Institutions Holding STAA

About STAAR SURGICAL CO


  • Ticker STAA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 48,038,300
  • Market Cap $1.31B
  • Description
  • STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatis...
More about STAA
Track This Portfolio

Track Exodus Point Capital Management, LP Portfolio

Follow Exodus Point Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.